Skip to content

ADMA Biologics ADMA Price / book

Price / book at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
1.1×+0.5×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
125.1×+108×
Zymeworks logo
ZymeworksZYME
11.4×+8.8×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
1.1×+0.1×
Quest Diagnostics logo
Quest DiagnosticsDGX
2.9×+0.2×
Biohaven logo
BiohavenBHVN
9.8×+0.4×

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

Based on the most recent quarter.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's price / book?
ADMA Biologics (ADMA) reported price / book of 5.5× in Q1 2026.
How has ADMA Biologics's price / book changed year-over-year?
ADMA Biologics's price / book decreased by 56.5% year-over-year, from 12.6× to 5.5×.
What is the long-term trend for ADMA Biologics's price / book?
Over 5 years (2020 to 2025), ADMA Biologics's price / book has grown at a 16.0% compound annual growth rate (CAGR), from 4.3× to 9.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.